Dmitry V. Kravchenko

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Non-equilibrium CO2 kinetics: Assessment of advanced multi-temperature models of vibrational–chemical relaxation2026
• State-to-state oxygen kinetics behind reflected shock waves: Assessment of different approaches2024
• The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-22022
• Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study2021
• Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients2021
• AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial2020 · аннотациясвернуть

  In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients. In the pilot stage of Phase II/III…

• Highly sensitive field test lateral flow immunodiagnostics of PVX infection2011
• Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors2007